The management board of Traphaco Joint Stock Co (coded TRA) has recently released the resolution for raising the holding ratio in High Tech Joint Stock Co (coded CNC) from 15 percent to 51 percent, using the method of purchasing shares in public.
At present, CNC has chartered capital of 34 billion dong. Last year, the company reported having positive business results with EPS of 16,206 dong. CNC has the first pharmaceutical plant in Vietnam with GMP-WHO standards, specialising in supplying pharmaceutical products for Traphaco.
In related news, Traphaco announced to gain Q2 after tax profit of 25.3 billion dong, a year-on-year increase of 53.62 percent.
The main reason for the positive growth was because in April-June period, the company’s revenue surged by 66.78 percent against the same period last year. The pharmaceutical firm has successfully focused on expanding the distribution network, together with suitable sales policies.